Comparing Intraperitoneal and Intravenous Personalized ErbB2CAR-T for the Treatment of Epithelial Ovarian Cancer.
Deshet-Unger N, Horn G, Rawet-Slobodkin M, Waks T, Laskov I, Michaan N, Raz Y, Bar V, Zundelevich A, Aharon S, Turovsky L, Mallel G, Salpeter S, Neev G, Hollander KS, Katz BZ, Grisaru D, Globerson Levin A.
Deshet-Unger N, et al. Among authors: globerson levin a.
Biomedicines. 2022 Sep 7;10(9):2216. doi: 10.3390/biomedicines10092216.
Biomedicines. 2022.
PMID: 36140319
Free PMC article.